These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 31505518)

  • 1. Hallucinogens and Their Therapeutic Use: A Literature Review.
    Begola MJ; Schillerstrom JE
    J Psychiatr Pract; 2019 Sep; 25(5):334-346. PubMed ID: 31505518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine.
    De Gregorio D; Aguilar-Valles A; Preller KH; Heifets BD; Hibicke M; Mitchell J; Gobbi G
    J Neurosci; 2021 Feb; 41(5):891-900. PubMed ID: 33257322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Registered clinical studies investigating psychedelic drugs for psychiatric disorders.
    Siegel AN; Meshkat S; Benitah K; Lipsitz O; Gill H; Lui LMW; Teopiz KM; McIntyre RS; Rosenblat JD
    J Psychiatr Res; 2021 Jul; 139():71-81. PubMed ID: 34048997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies.
    Breeksema JJ; Niemeijer AR; Krediet E; Vermetten E; Schoevers RA
    CNS Drugs; 2020 Sep; 34(9):925-946. PubMed ID: 32803732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Potential of Psychedelics in the Treatment of Psychiatric Disorders, Part 1: Psychopharmacology and Neurobiological Effects.
    Hosanagar A; Cusimano J; Radhakrishnan R
    J Clin Psychiatry; 2021 Feb; 82(2):. PubMed ID: 33988926
    [No Abstract]   [Full Text] [Related]  

  • 6. Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis.
    Goldberg SB; Shechet B; Nicholas CR; Ng CW; Deole G; Chen Z; Raison CL
    Psychol Med; 2020 Dec; 50(16):2655-2666. PubMed ID: 33143790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.
    De Gregorio D; Enns JP; Nuñez NA; Posa L; Gobbi G
    Prog Brain Res; 2018; 242():69-96. PubMed ID: 30471683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hallucinogenic drugs in psychiatric research and treatment. Perspectives and prospects.
    Strassman RJ
    J Nerv Ment Dis; 1995 Mar; 183(3):127-38. PubMed ID: 7891058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.
    Dos Santos RG; Bouso JC; Alcázar-Córcoles MÁ; Hallak JEC
    Expert Rev Clin Pharmacol; 2018 Sep; 11(9):889-902. PubMed ID: 30102078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychedelic drugs-a new era in
psychiatry?
.
    Nutt D
    Dialogues Clin Neurosci; 2019; 21(2):139-147. PubMed ID: 31636488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].
    Majić T; Jungaberle H; Schmidt TT; Zeuch A; Hermle L; Gallinat J
    Fortschr Neurol Psychiatr; 2017 Jul; 85(7):383-392. PubMed ID: 28768346
    [No Abstract]   [Full Text] [Related]  

  • 12. [Neurotrophic mechanisms of psychedelic therapy].
    Corne R; Mongeau R
    Biol Aujourdhui; 2019; 213(3-4):121-129. PubMed ID: 31829932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Potential of Psychedelics in Treatment of Psychiatric Disorders, Part 2: Review of the Evidence.
    Hosanagar A; Cusimano J; Radhakrishnan R
    J Clin Psychiatry; 2021 Feb; 82(3):. PubMed ID: 33988930
    [No Abstract]   [Full Text] [Related]  

  • 14. The adverse effects of hallucinogens from intramural perspective.
    Frecska E; Luna LE
    Neuropsychopharmacol Hung; 2006 Dec; 8(4):189-200. PubMed ID: 17211054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psilocybin: A brief overview for psychiatric mental health nurse practitioners.
    Fradkin D
    Perspect Psychiatr Care; 2022 Jul; 58(3):1200-1203. PubMed ID: 34101846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hallucinogenic substances. Their role in research and in current psychiatric therapy].
    Benoit JC
    Sem Ther; 1965 Jan; 41(1):28-33. PubMed ID: 5879030
    [No Abstract]   [Full Text] [Related]  

  • 17. Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders.
    Thomas K; Malcolm B; Lastra D
    J Psychoactive Drugs; 2017; 49(5):446-455. PubMed ID: 28481178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Applications of Classic Hallucinogens.
    Bogenschutz MP; Ross S
    Curr Top Behav Neurosci; 2018; 36():361-391. PubMed ID: 28512684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel psychotherapeutics - a cautiously optimistic focus on Hallucinogens.
    Sherwood AM; Prisinzano TE
    Expert Rev Clin Pharmacol; 2018 Jan; 11(1):1-3. PubMed ID: 29224406
    [No Abstract]   [Full Text] [Related]  

  • 20. [Classic psychedelic drugs and their potential therapeutic effect].
    Bayat M
    Ugeskr Laeger; 2017 Sep; 179(37):. PubMed ID: 28918777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.